You have open access to this content

BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β-catenin signalling

Ni Tang^1,2,
Wen-Xin Song²,
Jinyong Luo^1,2,
Xiaoji Luo^1,2,
Jin Chen^1,2,
Katie A. Sharff²,
Yang Bi^1,2,
Bai-Cheng He^1,2,
Jia-Yi Huang^1,2,
Gao-Hui Zhu^1,2,
Yu-Xi Su^1,2,
Wei Jiang²,
Min Tang¹,
Yun He^1,2,
Yi Wang^1,2,
Liang Chen^1,2,
Guo-Wei Zuo^1,2,
Jikun Shen²,
Xiaochuan Pan³,
Russell R. Reid²,
Hue H. Luu²,
Rex C. Haydon²,
Tong-Chuan He^1,2,*

Article first published online: 3 NOV 2008

DOI: 10.1111/j.1582-4934.2008.00569.x

Issue

Journal of Cellular and Molecular Medicine

Volume 13, Issue 8b, pages 2448–2464, August 2009

Total views since August 2010: 165

Additional Information

How to Cite

Tang, N., Song, W.-X., Luo, J., Luo, X., Chen, J., Sharff, K. A., Bi, Y., He, B.-C., Huang, J.-Y., Zhu, G.-H., Su, Y.-X., Jiang, W., Tang, M., He, Y., Wang, Y., Chen, L., Zuo, G.-W., Shen, J., Pan, X., Reid, R. R., Luu, H. H., Haydon, R. C. and He, T.-C. (2009), BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β-catenin signalling. Journal of Cellular and Molecular Medicine, 13: 2448–2464. doi: 10.1111/j.1582-4934.2008.00569.x

Author Information

¹
The Second Affiliated Hospital and the Key Laboratory of Diagnostic Medicine designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing, China
²
Molecular Oncology Laboratory, Department of Surgery, The University of Chicago Medical Center, Chicago, IL, USA
³
Department of Radiology, The University of Chicago Medical Center, Chicago, IL, USA

^* Correspondence to: T.-C. HE, M.D., Ph.D., Molecular Oncology Laboratory, The University of Chicago Medical Center, 5841 South Maryland Avenue, MC 3079, Chicago, IL 60637, USA Tel.: (773) 702-7169 Fax: (773) 834-4598 E-mail: tche@surgery.bsd.uchicago.edu

Publication History

Issue published online: 26 NOV 2009
Article first published online: 3 NOV 2008
Received: July 15, 2008; Accepted: October 21, 2008

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (2145K)

References

1
Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996; 10: 1580–94.
2
Ducy P, Karsenty G. The family of bone morphogenetic proteins. Kidney Int. 2000; 57: 2207–14.
3
Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003; 113: 685–700.
4
Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science. 2002; 296: 1646–7.
5
Luo J, Sun MH, Kang Q, et al . Gene therapy for bone regeneration. Curr Gene Ther. 2005; 5: 167–79.
6
Luu HH, Song WX, Luo X, et al . Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res. 2007; 25: 665–77.
Direct Link:
7
Deng ZL, Sharff KA, Tang N, et al . Regulation of osteogenic differentiation during skeletal development. Frontiers in Biosci. 2008; 13: 2001–21.
8
Song JJ, Celeste AJ, Kong FM, et al . Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology. 1995; 136: 4293–7.
9
Lopez-Coviella I, Berse B, Krauss R, et al . Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science. 2000; 289: 313–6.
10
Chen C, Grzegorzewski KJ, Barash S, et al . An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nat Biotechnol. 2003; 21: 294–301.
11
Truksa J, Peng H, Lee P, et al . Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci USA. 2006; 103: 10289–93.
12
Cheng H, Jiang W, Phillips FM, et al . Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am. 2003; 85-A: 1544–52.
- PubMed,
- Web of Science® Times Cited: 205
13
Kang Q, Sun MH, Cheng H, et al . Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther. 2004; 11: 1312–20.
14
Peng Y, Kang Q, Cheng H, et al . Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem. 2003; 90: 1149–65.
Direct Link:
15
Peng Y, Kang Q, Luo Q, et al . Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004; 279: 32941–9.
16
Luo Q, Kang Q, Si W, et al . Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004; 279: 55958–68.
17
Si W, Kang Q, Luu HH, et al . CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol. 2006; 26: 2955–64.
18
Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science. 2000; 289: 1501–4.
19
Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997; 276: 71–4.
20
Aubin JE. Bone stem cells. J Cell Biochem Suppl. 1998; 31: 73–82.
Direct Link:
21
Pittenger MF, Mackay AM, Beck SC, et al . Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143–7.
22
Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends in Mol Med. 2001; 7: 259–64.
23
Molofsky AV, Pardal R, Morrison SJ. Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol. 2004; 16: 700–7.
24
Wang J, Wynshaw-Boris A. The canonical Wnt pathway in early mammalian embryogenesis and stem cell maintenance/ differentiation. Curr Opin Genet Dev. 2004; 14: 533–9.
25
Kleber M, Sommer L. Wnt signaling and the regulation of stem cell function. Curr Opin Cell Biol. 2004; 16: 681–7.
26
Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005; 434: 843–50.
27
Luo J, Chen J, Deng ZL, et al . Wnt signaling and human diseases: what are the therapeutic implications Lab Invest. 2007; 87: 97–103.
28
Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002; 2: 389–406.
29
Varga AC, Wrana JL. The disparate role of BMP in stem cell biology. Oncogene. 2005; 24: 5713–21.
30
Zhang J, Li L. BMP signaling and stem cell regulation. Dev Biol. 2005; 284: 1–11.
31
Zhao GQ. Consequences of knocking out BMP signaling in the mouse. Genesis. 2003; 35: 43–56.
Direct Link:
32
Urist MR. Bone: formation by autoinduction. Science. 1965; 150: 893–9.
33
Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol. 1998; 16: 247–52.
34
Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 1997; 11: 3286–305.
35
Glass DA, 2nd, Karsenty G. In vivo analysis of Wnt signaling in bone. Endocrinology. 2007; 148: 2630–4.
36
Bergwitz C, Wendlandt T, Kispert A, et al . Wnts differentially regulate colony growth and differentiation of chondrogenic rat calvaria cells. Biochim Biophys Acta. 2001; 1538: 129–40.
37
Fischer L, Boland G, Tuan RS. Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J Cell Biochem. 2002; 84: 816–31.
Direct Link:
38
Glass DA, 2nd, Karsenty G. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway. Curr Top Dev Biol. 2006; 73: 43–84.
39
Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol. 1998; 14: 59–88.
40
Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006; 127: 469–80.
41
He TC, Sparks AB, Rago C, et al . Identification of c-MYC as a target of the APC pathway. Science. 1998; 281: 1509–12.
42
Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999; 398: 422–6.
43
He TC, Chan TA, Vogelstein B, et al . PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999; 99: 335–45.
44
Gong Y, Slee RB, Fukai N, et al . LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001; 107: 513–23.
45
Little RD, Recker RR, Johnson ML. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med. 2002; 347: 943–4; author reply 4.
46
Boyden LM, Mao J, Belsky J, et al . High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med. 2002; 346: 1513–21.
47
Chen Y, Whetstone HC, Lin AC, et al . Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med. 2007; 4: e249.
48
Kahler RA, Westendorf JJ. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. J Biol Chem. 2003; 278: 11937–44.
49
De Boer J, Siddappa R, Gaspar C, et al . Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone. 2004; 34: 818–26.
50
Boland GM, Perkins G, Hall DJ, et al . Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem. 2004; 93: 1210–30.
Direct Link:
51
Van Der Horst G, Van Der Werf SM, Farih-Sips H, et al . Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells. J Bone Miner Res. 2005; 20: 1867–77.
Direct Link:
52
Kahler RA, Galindo M, Lian J, et al . Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts. J Cell Biochem. 2006; 97: 969–83.
Direct Link:
53
Tu X, Joeng KS, Nakayama KI, et al . Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. Dev Cell. 2007; 12: 113–27.
54
Chang J, Sonoyama W, Wang Z, et al . Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J Biol Chem. 2007; 282: 30938–48.
55
Lengner CJ, Lepper C, Van Wijnen AJ, et al . Primary mouse embryonic fibroblasts: a model of mesenchymal cartilage formation. J Cell Physiol. 2004; 200: 327–33.
Direct Link:
56
Luo Q, Kang Q, Song WX, et al . Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. Gene. 2007; 395: 160–9.
57
He TC, Zhou S, Da Costa LT, et al . A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA. 1998; 95: 2509–14.
58
Luo J, Deng ZL, Luo X, et al . A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc. 2007; 2: 1236–47.
59
Zhou L, An N, Jiang W, et al . Fluorescence-based functional assay for Wnt/beta-catenin signaling activity. Biotechniques. 2002; 33: 1126–8.
60
He TC. Distinct osteogenic activity of BMPs and their orthopaedic applications. Journal of Musculoskeletal & Neuronal Interactions. 2005; 5: 363–6.
- PubMed,
- CAS
61
Morin PJ, Sparks AB, Korinek V, et al . Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997; 275: 1787–90.
62
Luu HH, Zhang R, Haydon RC, et al . Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets. 2004; 4: 653–71.
63
Yoshizawa T, Takizawa F, Iizawa F, et al . Homeobox protein MSX2 acts as a molecular defense mechanism for preventing ossification in ligament fibroblasts. Mol Cell Biol. 2004; 24: 3460–72.
64
Gordon MD, Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem. 2006; 281: 22429–33.
65
Sparks AB, Morin PJ, Vogelstein B, et al . Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 1998; 58: 1130–4.
66
Ducy P, Zhang R, Geoffroy V, et al . Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997; 89: 747–54.
67
Ducy P, Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol. 1995; 15: 1858–69.
68
Nohe A, Keating E, Knaus P, et al . Signal transduction of bone morphogenetic protein receptors. Cell Signal. 2004; 16: 291–9.
69
Nakashima A, Katagiri T, Tamura M. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J Biol Chem. 2005; 280: 37660–8.
70
Katoh M. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev. 2007; 3: 30–8.
71
Xiao G, Jiang D, Ge C, et al . Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J Biol Chem. 2005; 280: 30689–96.
72
Reinhold MI, Naski MC. Direct interactions of Runx2 and canonical Wnt signaling induce FGF18. J Biol Chem. 2007; 282: 3653–63.
73
Rawadi G, Vayssiere B, Dunn F, et al . BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res. 2003; 18: 1842–53.
Direct Link:
74
Chen Y, Whetstone HC, Youn A, et al . Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation. J Biol Chem. 2007; 282: 526–33.
75
Mbalaviele G, Sheikh S, Stains JP, et al . Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J Cell Biochem. 2005; 94: 403–18.
Direct Link:
76
Nishita M, Hashimoto MK, Ogata S, et al . Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann’s organizer. Nature. 2000; 403: 781–5.
77
Hu MC, Piscione TD, Rosenblum ND. Elevated SMAD1/beta-catenin molecular complexes and renal medullary cystic dysplasia in ALK3 transgenic mice. Development. 2003; 130: 2753–66.
78
Hussein SM, Duff EK, Sirard C. Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem. 2003; 278: 48805–14.
79
Hu MC, Rosenblum ND. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development. 2005; 132: 215–25.
80
Gaur T, Lengner CJ, Hovhannisyan H, et al . Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem. 2005; 280: 33132–40.
81
MacDonald BT, Joiner DM, Oyserman SM, et al . Bone mass is inversely proportional to Dkk1 levels in mice. Bone. 2007; 41: 331–9.
82
Li X, Liu P, Liu W, et al . Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet. 2005; 37: 945–52.
83
Holmen SL, Zylstra CR, Mukherjee A, et al . Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem. 2005; 280: 21162–8.
84
Day TF, Guo X, Garrett-Beal L, et al . Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell. 2005; 8: 739–50.
85
Glass DA, 2nd, Bialek P, Ahn JD, et al . Canonical Wnt signaling in differen-tiated osteoblasts controls osteoclast differentiation. Dev Cell. 2005; 8: 751–64.
86
Hill TP, Spater D, Taketo MM, et al . Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell. 2005; 8: 727–38.
87
Tamai K, Semenov M, Kato Y, et al . LDL-receptor-related proteins in Wnt signal transduction. Nature. 2000; 407: 530–5.
88
Bodine PV, Billiard J, Moran RA, et al . The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J Cell Biochem. 2005; 96: 1212–30.
Direct Link:
89
Kato M, Patel MS, Levasseur R, et al . Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol. 2002; 157: 303–14.
90
Morvan F, Boulukos K, Clement-Lacroix P, et al . Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res. 2006; 21: 934–45.
Direct Link:
91
Li J, Sarosi I, Cattley RC, et al . Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia. Bone. 2006; 39: 754–66.

View Full Article with Supporting Information (HTML) Get PDF (2145K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β-catenin signalling

Journal of Cellular and Molecular Medicine

How to Cite

Author Information

Publication History

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β-catenin signalling

Journal of Cellular and Molecular Medicine

How to Cite

Author Information

Publication History

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this